PTC Therapeutics (PTCT) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
PTC Therapeutics (PTCT) PT Lowered to $30 at RBC Capital
May 10, 2018 8:51 AM EDTRBC Capital lowered its price target on PTC Therapeutics (NASDAQ: PTCT) to $30.00 (from $31.00) while maintaining a Sector Perform rating.
... More